Published in Nat Rev Cardiol on February 08, 2011
In vivo characterization of a new abdominal aortic aneurysm mouse model with conventional and molecular magnetic resonance imaging. J Am Coll Cardiol (2011) 1.65
Inhibition of Notch1 signaling reduces abdominal aortic aneurysm in mice by attenuating macrophage-mediated inflammation. Arterioscler Thromb Vasc Biol (2012) 0.89
Metabolomics with LC-QTOF-MS permits the prediction of disease stage in aortic abdominal aneurysm based on plasma metabolic fingerprint. PLoS One (2012) 0.86
Molecular imaging of experimental abdominal aortic aneurysms. ScientificWorldJournal (2013) 0.81
Molecular imaging of aortic aneurysms. Circ Cardiovasc Imaging (2012) 0.81
Cardiovascular defense challenges at the basic, clinical, and population levels. Ann N Y Acad Sci (2012) 0.79
Periadventitial adipose-derived stem cell treatment halts elastase-induced abdominal aortic aneurysm progression. Regen Med (2014) 0.79
Abdominal aortic aneurysms targeted by functionalized polysaccharide microparticles: a new tool for SPECT imaging. Theranostics (2014) 0.79
Imaging of small animal peripheral artery disease models: recent advancements and translational potential. Int J Mol Sci (2015) 0.79
Polysaccharide nanosystems for future progress in cardiovascular pathologies. Theranostics (2014) 0.78
Perspectives on stem cell-based elastic matrix regenerative therapies for abdominal aortic aneurysms. Stem Cells Transl Med (2013) 0.77
Melatonin attenuates angiotensin II-induced abdominal aortic aneurysm through the down-regulation of matrix metalloproteinases. Oncotarget (2017) 0.75
Nanomedicine as a strategy to fight thrombotic diseases. Future Sci OA (2015) 0.75
The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet (2002) 10.52
Endovascular versus open repair of abdominal aortic aneurysm. N Engl J Med (2010) 7.83
Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med (2002) 7.35
Abdominal aortic aneurysm. Lancet (2005) 4.59
Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation (2002) 4.43
Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study. Lancet (2006) 4.10
Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR trial 2): randomised controlled trial. Lancet (2005) 4.09
Long-term outcome of open or endovascular repair of abdominal aortic aneurysm. N Engl J Med (2010) 3.70
Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat Med (2005) 3.59
A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet (2009) 3.55
Influence of screening on the incidence of ruptured abdominal aortic aneurysm: 5-year results of a randomized controlled study. Br J Surg (1995) 3.23
Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group. Ann Intern Med (1997) 3.08
Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation (2004) 3.07
Time-resolved 3D MR velocity mapping at 3T: improved navigator-gated assessment of vascular anatomy and blood flow. J Magn Reson Imaging (2007) 2.93
An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. J Clin Invest (2009) 2.86
The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. Arch Intern Med (2000) 2.78
Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med (2002) 2.73
Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm. BMJ (2004) 2.70
Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation (2001) 2.70
Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation. Circulation (2005) 2.67
Elastase-induced experimental aneurysms in rats. Circulation (1990) 2.50
Screening for abdominal aortic aneurysms: single centre randomised controlled trial. BMJ (2005) 2.33
Screening for abdominal aortic aneurysm reduces overall mortality in men. A meta-analysis of the mid- and long-term effects of screening for abdominal aortic aneurysms. Eur J Vasc Endovasc Surg (2008) 2.32
TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. J Clin Invest (2010) 2.32
Growth predictors and prognosis of small abdominal aortic aneurysms. J Vasc Surg (2008) 2.31
Randomized double-blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion. Br J Surg (2001) 2.24
Preliminary ten year results from a randomised single centre mass screening trial for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg (2006) 2.19
Association between osteopontin and human abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol (2006) 2.14
Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice. J Exp Med (2009) 2.12
Fifteen-year follow-up of a randomized clinical trial of ultrasonographic screening for abdominal aortic aneurysms. Br J Surg (2007) 2.04
Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice. J Clin Invest (2007) 2.00
Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol (1997) 1.74
High levels of 18F-FDG uptake in aortic aneurysm wall are associated with high wall stress. Eur J Vasc Endovasc Surg (2009) 1.66
Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J Vasc Surg (1996) 1.66
Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J Vasc Surg (2002) 1.64
Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Am J Pathol (2002) 1.63
Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice. J Vasc Surg (2002) 1.57
Nanotechnology in medical imaging: probe design and applications. Arterioscler Thromb Vasc Biol (2008) 1.55
Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms. J Vasc Surg (2000) 1.50
The influence of screening on the incidence of ruptured abdominal aortic aneurysms. J Vasc Surg (1999) 1.49
The validity of ultrasonographic scanning as screening method for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg (1999) 1.38
Limitations of ultrasonography in surveillance of small abdominal aortic aneurysms. Br J Surg (1991) 1.35
Critical role of dipeptidyl peptidase I in neutrophil recruitment during the development of experimental abdominal aortic aneurysms. Proc Natl Acad Sci U S A (2007) 1.32
Correlation of inflammatory infiltrate with the enlargement of experimental aortic aneurysms. J Vasc Surg (1992) 1.29
Biomarkers of abdominal aortic aneurysm progression. Part 2: inflammation. Nat Rev Cardiol (2009) 1.17
Presence of NGAL/MMP-9 complexes in human abdominal aortic aneurysms. Thromb Haemost (2007) 1.16
Long-term durability of open abdominal aortic aneurysm repair. J Vasc Surg (2007) 1.15
Biomarkers of AAA progression. Part 1: extracellular matrix degeneration. Nat Rev Cardiol (2009) 1.15
Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins. Am J Cardiol (2005) 1.14
Detection, management, and prospects for the medical treatment of small abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol (2003) 1.14
Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur J Vasc Endovasc Surg (2006) 1.13
Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice. Ann Surg (2005) 1.12
In vivo imaging of abdominal aortic aneurysms: increased FDG uptake suggests inflammation in the aneurysm wall. J Endovasc Ther (2008) 1.12
Topology of the fibrinolytic system within the mural thrombus of human abdominal aortic aneurysms. J Pathol (2007) 1.11
Magnetic resonance imaging identifies the fibrous cap in atherosclerotic abdominal aortic aneurysm. Circulation (2004) 1.11
Propranolol for small abdominal aortic aneurysms: results of a randomized trial. J Vasc Surg (2002) 1.11
Cytokines as plasma markers of abdominal aortic aneurysm. Clin Chem Lab Med (2000) 1.11
Cell-free arterial grafts: morphologic characteristics of aortic isografts, allografts, and xenografts in rats. J Vasc Surg (1994) 1.08
Positron emission tomography (PET) evaluation of abdominal aortic aneurysm (AAA). Eur J Vasc Endovasc Surg (2002) 1.08
Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution. Am J Pathol (2006) 1.08
Role of leukocyte elastase in preventing cellular re-colonization of the mural thrombus. Am J Pathol (2004) 1.07
Multidirectional flow analysis by cardiovascular magnetic resonance in aneurysm development following repair of aortic coarctation. J Cardiovasc Magn Reson (2008) 1.06
Molecular imaging of cardiovascular disease using ultrasound. J Nucl Cardiol (2008) 1.06
Effect of beta-adrenergic blockade on the growth rate of abdominal aortic aneurysms. Arch Surg (1988) 1.06
Growth rates and risk of rupture of abdominal aortic aneurysms. Br J Surg (1998) 1.04
Evaluation of the aortic root by MRI: insights from patients with homozygous familial hypercholesterolemia. Circulation (1998) 1.04
The association between cigarette smoking and abdominal aortic aneurysms. J Vasc Surg (1999) 1.03
Accuracy of serial screening for abdominal aortic aneurysms by ultrasound. J Med Screen (2002) 1.03
Multimodality nanotracers for cardiovascular applications. Nat Clin Pract Cardiovasc Med (2008) 1.01
Bleeding into the intraluminal thrombus in abdominal aortic aneurysms is associated with rupture. J Vasc Surg (2008) 1.01
Mediators of neutrophil recruitment in human abdominal aortic aneurysms. Cardiovasc Res (2009) 1.01
Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue. Eur J Vasc Endovasc Surg (2007) 0.99
The PIVOTAL study: a randomized comparison of endovascular repair versus surveillance in patients with smaller abdominal aortic aneurysms. J Vasc Surg (2009) 0.99
Reducing protein concentration range of biological samples using solid-phase ligand libraries. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.99
Ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging of abdominal aortic aneurysms--a feasibility study. Eur J Vasc Endovasc Surg (2010) 0.99
Recent advances in molecular mechanisms of abdominal aortic aneurysm formation. World J Surg (2008) 0.98
Matrix biology of abdominal aortic aneurysms in diabetes: mechanisms underlying the negative association. Connect Tissue Res (2007) 0.97
Abdominal aortic aneurysm expansion rate: effect of size and beta-adrenergic blockade. J Vasc Surg (1994) 0.97
Learning from the last ultrasound. A population-based study of patients with abdominal aortic aneurysm. Arch Intern Med (1997) 0.96
Risk factors associated with rapid growth of small abdominal aortic aneurysms. Surgery (1997) 0.95
Magnetic resonance molecular imaging of thrombosis in an arachidonic acid mouse model using an activated platelet targeted probe. Arterioscler Thromb Vasc Biol (2010) 0.95
Five-year results of elastin and collagen markers as predictive tools in the management of small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg (2001) 0.93
Inhibition of macrophage phagocytotic activity by a receptor-targeted polymer vesicle-based drug delivery formulation of pravastatin. J Cardiovasc Pharmacol (2008) 0.91
Contrasting outcomes of atheroma evolution: intimal accumulation versus medial destruction. Arterioscler Thromb Vasc Biol (2001) 0.91
Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue. Neoplasia (2008) 0.91
Medical management of abdominal aortic aneurysm. Eur J Vasc Endovasc Surg (2007) 0.89
Interpretation of the results of OVER in the context of EVAR trial, DREAM, and the EUROSTAR registry. Semin Vasc Surg (2010) 0.89
Dynamics of the aorta before and after endovascular aneurysm repair: a systematic review. Eur J Vasc Endovasc Surg (2009) 0.88
Macrophage migration inhibitory factor is associated with aneurysmal expansion. J Vasc Surg (2003) 0.88
Effect of blocking platelet activation with AZD6140 on development of abdominal aortic aneurysm in a rat aneurysmal model. J Vasc Surg (2008) 0.88
Involvement of vascular angiotensin II-forming enzymes in the progression of aortic abdominal aneurysms in angiotensin II- infused ApoE-deficient mice. J Atheroscler Thromb (2009) 0.87
Initial results of ultrasound screening for aneurysm of the abdominal aorta in Western Australia: relevance for endoluminal treatment of aneurysm disease. Cardiovasc Surg (2001) 0.87
The effect of azithromycin and Chlamydophilia pneumonia infection on expansion of small abdominal aortic aneurysms--a prospective randomized double-blind trial. J Vasc Surg (2009) 0.84
Indicators of infection with Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysms. J Vasc Surg (2001) 0.83
Aortic compliance following EVAR and the influence of different endografts: determination using dynamic MRA. J Endovasc Ther (2006) 0.83
Lymphoid neogenesis in chronic rejection. Curr Opin Organ Transplant (2008) 0.83
Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet (2003) 11.01
Strategies for multivessel revascularization in patients with diabetes. N Engl J Med (2012) 10.79
Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science (2006) 10.25
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
Quantifying the evolutionary dynamics of language. Nature (2007) 6.12
Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. JAMA (2005) 5.83
Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev (2006) 5.27
Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nat Med (2007) 5.25
Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. Nat Genet (2011) 4.81
The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. J Am Coll Cardiol (2013) 4.81
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet (2011) 4.67
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2010) 4.56
ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol (2002) 4.48
Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med (2006) 4.28
Imaging of atherosclerotic cardiovascular disease. Nature (2008) 4.14
Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation (2008) 3.69
Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet (2006) 3.65
Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation (2003) 3.55
Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med (2007) 3.40
Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation (2012) 3.38
Accuracy of 64-slice computed tomography to classify and quantify plaque volumes in the proximal coronary system: a comparative study using intravascular ultrasound. J Am Coll Cardiol (2006) 3.36
Atherothrombosis and high-risk plaque: part I: evolving concepts. J Am Coll Cardiol (2005) 3.34
Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study. J Am Coll Cardiol (2013) 3.25
Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res (2004) 3.03
Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc Natl Acad Sci U S A (2007) 2.99
Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform. Nano Lett (2008) 2.98
Endosomal escape pathways for delivery of biologicals. J Control Release (2010) 2.90
Evolutionary paths to antibiotic resistance under dynamically sustained drug selection. Nat Genet (2011) 2.86
B cell depletion reduces the development of atherosclerosis in mice. J Exp Med (2010) 2.79
Immunopathology of schistosomiasis. Immunol Cell Biol (2006) 2.74
Training cardiovascular fellows in cardiovascular magnetic resonance and vascular imaging; Current status following the core cardiovascular training symposium (COCATS-2) guidelines. J Am Coll Cardiol (2004) 2.67
Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. JACC Cardiovasc Imaging (2009) 2.56
Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med (2008) 2.52
American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation (2003) 2.52
Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage study. JACC Cardiovasc Imaging (2012) 2.50
Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantation. J Am Coll Cardiol (2010) 2.50
Neovascularization in human atherosclerosis. Circulation (2006) 2.44
Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles. Radiology (2010) 2.43
Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. J Control Release (2011) 2.37
(18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol (2007) 2.32
TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. J Clin Invest (2010) 2.32
OCT-based diagnosis and management of STEMI associated with intact fibrous cap. JACC Cardiovasc Imaging (2013) 2.31
Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation (2004) 2.30
Aspirin and clopidogrel in acute coronary syndromes: therapeutic insights from the CURE study. Arch Intern Med (2003) 2.29
Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J Am Coll Cardiol (2005) 2.23
Inflammation and angiotensin II. Int J Biochem Cell Biol (2003) 2.22
Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis. Arterioscler Thromb Vasc Biol (2007) 2.21
Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol (2005) 2.20
Fibrillins 1 and 2 perform partially overlapping functions during aortic development. J Biol Chem (2005) 2.19
Lactadherin promotes VEGF-dependent neovascularization. Nat Med (2005) 2.19
Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol (2013) 2.18
Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J Exp Med (2009) 2.17
Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. Circulation (2004) 2.16
Sheddable coatings for long-circulating nanoparticles. Pharm Res (2007) 2.15